Skip to main content

MINI REVIEW article

Front. Med.
Sec. Precision Medicine
Volume 11 - 2024 | doi: 10.3389/fmed.2024.1415940
This article is part of the Research Topic Revolutionizing Cancer Care: The Promise of Liquid Biopsy Assays for Healthcare Equity View all 4 articles

Is the development of liquid biopsy for the early detection and the monitoring of breast cancers on its way of overtaking mammography?

Provisionally accepted
Hicham Mansour Hicham Mansour 1*Chakib Nejjari Chakib Nejjari 2Roberto Incitti Roberto Incitti 3Naima Anouar Naima Anouar 1Abdelhak Ouhajjou Abdelhak Ouhajjou 4
  • 1 Mohamed Premier University, Oujda, Morocco
  • 2 Euromed University, Fez, Fes-Meknes, Morocco
  • 3 King Abdullah University of Science and Technology, Thuwal, Makkah, Saudi Arabia
  • 4 Al Azhar Oncology Center, Rabat, Morocco

The final, formatted version of the article will be published soon.

    Mammography, as of today, is used as gold standard for screening, diagnosing and monitoring breast cancer (BC). While being overall beneficial, it has several downsides, like limitation in accuracy, relatively high cost and the dependence on a heavy infrastructure, hence a lesser accessibility to the entire global target population. There is currently no established alternative to mammography and overcoming this major challenge is a hot research and technology topic. One of the avenues for tackling this issue, is the development of highly sensitive and specific non-invasive blood tests for the early diagnosis and the follow up of breast cancer. This paper discusses the limitations of mammography and recapitulates the blood tests already available, under development and the future developments in this field.

    Keywords: breast cancer, blood test, screening, diagnosis, Follow up, Treatment guidance, non-invasive, Genetic Test Mis en forme : Motif : Transparente

    Received: 11 Apr 2024; Accepted: 22 Jul 2024.

    Copyright: © 2024 Mansour, Nejjari, Incitti, Anouar and Ouhajjou. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Hicham Mansour, Mohamed Premier University, Oujda, Morocco

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.